Literature DB >> 11508343

Role of receptor editing and revision in shaping the B and T lymphocyte repertoire.

V Kouskoff1, D Nemazee.   

Abstract

B and T lymphocytes that carry antigen receptors are able to change specificity through subsequent receptor gene rearrangements. Receptor editing and receptor revision are terms used to distinguish those rearrangements occurring, respectively, in central lymphoid organs and the periphery. Secondary rearrangement appears to be a major player at two levels in the life of B lymphocytes. First, editing preserves a diverse repertoire without compromising self-tolerance, and revision further increases this repertoire once B cells have been engaged in an immune response, most likely for a better interaction with microbes. Recent studies have likewise suggested a role for receptor editing and revision in shaping the T cell repertoire during development and tolerance.

Mesh:

Substances:

Year:  2001        PMID: 11508343     DOI: 10.1016/s0024-3205(01)01219-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

2.  Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.

Authors:  Shuhei Karakawa; Satoshi Okada; Miyuki Tsumura; Yoko Mizoguchi; Norioki Ohno; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Tomoki Kawai; Ryuta Nishikomori; Takemasa Sakaguchi; Yoshihiro Takihara; Masao Kobayashi
Journal:  J Clin Immunol       Date:  2011-07-01       Impact factor: 8.317

3.  Laser capture microdissection and single-cell RT-PCR without RNA purification.

Authors:  Kathryne Melissa Keays; Gregory P Owens; Alanna M Ritchie; Donald H Gilden; Mark P Burgoon
Journal:  J Immunol Methods       Date:  2005-07       Impact factor: 2.303

4.  Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies.

Authors:  Mark P Burgoon; Kathryne M Keays; Gregory P Owens; Alanna M Ritchie; Pradeep R Rai; Carlyne D Cool; Donald H Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 5.  V(H) replacement in rearranged immunoglobulin genes.

Authors:  John M Darlow; David I Stott
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

6.  Analysis of RAG expression by peripheral blood CD5+ and CD5- B cells of patients with childhood systemic lupus erythematosus.

Authors:  H Morbach; S K Singh; C Faber; P E Lipsky; H J Girschick
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

7.  T cells from epicutaneously immunized mice are prone to T cell receptor revision.

Authors:  Margaret S Bynoe; Christophe Viret; Richard A Flavell; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

8.  Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.

Authors:  Jeffrey L Bennett; Chiwah Lam; Sudhakar Reddy Kalluri; Philippe Saikali; Katherine Bautista; Cecily Dupree; Magdalena Glogowska; David Case; Jack P Antel; Gregory P Owens; Don Gilden; Stefan Nessler; Christine Stadelmann; Bernhard Hemmer
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

9.  Functional silencing is initiated and maintained in immature anti-insulin B cells.

Authors:  Rachel A Henry; Carlos A Acevedo-Suárez; James W Thomas
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node.

Authors:  Laura Mandik-Nayak; Brian T Wipke; Fei F Shih; Emil R Unanue; Paul M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.